Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/10/058514
CTRI/2023/10/058514
Not yet recruiting
未知

Evaluation of effectiveness and safety of oral tofacitinib in patients with Parthenium dermatitis: A prospective interventional open label study - NI

AIIMS, New Delhi0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
AIIMS, New Delhi
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
AIIMS, New Delhi

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with airborne contact dermatitis with positive patch test to Parthenium, having a Parthenium Dermatitis Severity Score (PDSS) of more than or equal to 10\.
  • •2\. Patients more than or equal to 18 years of age.
  • •3\. Consenting patients who are willing to undergo treatment and report for follow up.

Exclusion Criteria

  • •1\. Patients with significant and active liver, renal or haematological disease.
  • •2\. Patients \< 18 years of age.
  • •3\. Pregnant and lactating females.
  • •4\. Patients with active or latent TB.
  • •5\. Patients with a lymphocyte count less than 500 cells/mm3, an absolute neutrophil count less than 1000 cells/mm3, or hemoglobin level less than 9 g/dL.
  • •6\. Patients with active infections.
  • •7\. Patients with history of thromboembolic phenomenon or on anticoagulants
  • •8\. Patients on immunosuppressive therapy in the last 4 weeks.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
The evaluation of the efficacy and safety of oral fingolimod in relapsing remitting multiple sclerosismultiple sclerosis.Disseminated Multiple Sclerosis
IRCT201406018323N10Vice-chancellor for research, Kermanshah University of Medical Sciences60
Active, not recruiting
Not Applicable
Study to assess the efficacy and safety of oral potassium citrate on the Prevention of nephrocalcinosis in extreme premature. Study PRENECAincidence of nephrocalcinosis in extremely preterm infantsMedDRA version: 14.1Level: PTClassification code 10029146Term: NephrocalcinosisSystem Organ Class: 10038359 - Renal and urinary disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
EUCTR2012-000298-22-ESFundació Clínic per a la Recerca Biomèdica
Not yet recruiting
Phase 3
Study to compare the effectiveness and safety of two drugs in atopic dermatitis in childre
CTRI/2024/02/063274IMS and SUM Hospital
Not yet recruiting
Not Applicable
To observe the efficacy of oral fluconazole versus 5% amrolfine nail lacquer in the patients of Onychomycosis.Health Condition 1: L609- Nail disorder, unspecified
CTRI/2020/12/029904Dr Ruchir M Bhatt
Completed
Not Applicable
Effectiveness and safety of oral and intralesional tranexamic acid in treatment of melasmaHealth Condition 1: L811- ChloasmaHealth Condition 2: O- Medical and Surgical
CTRI/2021/08/035350Department of Dermatology42